Searched for
BRISTOL MYERS
Pathos AI teams up with Bristol Myers and Tempus AI to advance drug developmentPathos AI said on Friday it had entered into a collaboration with Bristol Myers Squibb and Tempus AI to develop artificial intelligence too...- AstraZeneca strikes $40 million AI drug discovery deal with insitroAstraZeneca has entered a collaboration with insitro to explore new treatment options for challenging liver and heart diseases. The partner...
- AstraZeneca strikes $40 million AI drug discovery deal with insitroAstraZeneca has entered into a partnership with insitro to identify treatments for challenging liver and heart diseases. This collaboration...
- In 1944, a retired IRS auditor Anne Scheiber invested $5,000 in stocks; 51 years later, her portfolio was worth $22 millionAnne Scheiber reportedly retired in the mid-1940s with an annual salary of about $3,150. She had never been promoted. Her pay had also chan...
- Anthropic quietly sets up biology lab as it ramps AI drug programAt a time when fears of AI are gripping the public, the startup has built a wet lab, or place for physical experiments, in the San Francisc...
- Sun Pharma among 9 pharmaceutical firms to lower drug prices for Americans, Trump saysNine pharmaceutical firms reached deals with the Trump administration for lower drug prices. These agreements expand the total number of co...
- 'No discussions' over AstraZeneca-Bristol Myers deal, senior source saysAstraZeneca and Bristol Myers Squibb have denied any ongoing merger discussions. A senior source close to the matter stated no deal was eve...
- Bristol Myers buys Nvidia's latest AI computing system for drug researchBristol Myers Squibb is buying Nvidia's latest AI computing system. This new system will support artificial intelligence in drug discovery ...
- Syngene expands research collaboration with Bristol Myers SquibbSyngene International has extended its research partnership with Bristol Myers Squibb until 2035. This expanded agreement covers more servi...
- Biocon arm widens partnership terms with Bristol-Myers SquibbAs part of the expansion, Syngene will set up a new dedicated facility spread across 25,000 sq ft of laboratory and office space for Bristo...
- Biocon’s unit extends partnership with US-based Bristol-Myers SquibbThe two cos announced to renew their engagement, boosted by encouraging results in last 5 years, during when 6 drug molecules have been bro...
- Bristol-Myers sues Dr Reddy's Laboratories for patent infringement in USBristol-Myers Squibb Company has filed patent infringement case against Dr Reddy's Laboratories over the cancer drug Ixempra.
- Biocon close to oral insulin deal with Bristol-Myers SquibbFour months after its partnership with Pfizer fell through, Biocon is now close to inking a deal with US-based biopharmaceuticals giant Bri...
- Bristol-Myers Squibb to acquire Amylin for USD 5.3 billionBristol-Myers Squibb will acquire drug maker Amylin for USD 5.3 billion, a move that will strengthen its position in the diabetic medicines...
- Bristol-Myers offers $3.5 bn for Amylin: ReportsShares of Amylin Pharmaceuticals Inc rose as much as 51 percent as the company rejected a $3.5 billion unsolicited takeover bid from Bristo...
- Biocon's Syngene, Bristol-Myers Squibb open new R&D unitWhile current global economic slowdown has prompted many companies to cut down on their R&D spends and/or suspend research on certain molec...
- Syngene signs agreement with Bristol-MyersBiocon’s subsidiary company Syngene said it has entered into a research partnership with Bristol-Myers Squibb.
- Biocon subsi ties up with Bristol-Myers SquibbIntegrated biotechnology firm Biocon on Wednesday said its subsidiary Syngene has entered into a research partnership with global pharma ma...
- Schering-Plough, Sanofi set sights on Bristol-MyersBristol-Myers Squibb, which fired its chief executive officer this week, may be targeted for takeover by Schering-Plough or French drugmake...
- Drugmakers eye Bristol-MyersSeveral of the world’s top drugmakers may weigh acquiring Bristol-Myers Squibb after it fired its chief executive, although suitors seem un...
Load More
